Oak Street Health downgraded to Hold from Buy at Stifel

Stifel analyst Craig Jones downgraded Oak Street Health (OSH) to Hold from Buy with an unchanged price target of $39 after CVS Health (CVS) announced a deal to acquire Oak Street for $39 per share as the WSJ reported was in the works earlier this week. The acquisition, which is expected to close in 2023, "makes a lot of sense for both companies," the firm argues.